SeminarRecording AvailableMedicine

Post-traumatic headache

Schedule
Thursday, February 24, 2022
16:00 UTC
David Dodick

Prof

Department of Neurology, Mayo Clinic, Scottsdale Arizona, USA

Host: The Brain Prize Series

Recording

Event Information

Recording

Available

Host

The Brain Prize Series

Duration

70 minutes

Abstract

Concussion (mild traumatic brain injury) affects approximately 50 million people annually. Headache is the most common symptom after concussion and persists in up to 50% of those affected for at least one-year. The biological underpinnings of and the efficacy and tolerability of treatments for post-traumatic headache has historically received little attention. While treatment in clinical practice is mostly directly at the underlying phenotype of the headache, persistent post-traumatic headache is considered to be less responsive to treatments used to treat migraine or tension-type headache. Over the past several years, significant pre-clinical research has begun to elucidate the mechanism(s) involved in the development of post-traumatic headache, and a concerted effort to evaluate the efficacy of selected treatments for persistent post-traumatic headache has begun. This presentation will review the epidemiology, pathophysiology, and emerging data on the prevention and treatment of post-traumatic headache.

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.